Budipine: A New Chemical Substance in the Treatment of Parkinson’s Disease

Author(s):  
J. Siegfried ◽  
R. Fischer
2021 ◽  
Vol 23 (06) ◽  
pp. 1468-1473
Author(s):  
Singa Reddy Bhagya Lakshmi ◽  
◽  
Siri S Gowda ◽  
Trisha A ◽  
◽  
...  

Parkinson’s disease is a neurological disorder that affects the neurons that produce a chemical substance known as dopamine. The symptoms of this disease are tremors, stiffness all around the body, vocal impairment. If not treated early this disease might even lead to death. This disease doesn’t have a treatment, but an early prediction might help in the reduction of the progress of the disease. Detecting the disease is much more difficult as there is no quantitative test that can be conducted to detect the disease. Voice is one of the primary symptoms of this disease and therefore the features present in the voice can be extracted and can be used to train a model to detect whether the person is suffering from the disease or not. An ensemble learning voting classifier algorithm is designed with a performance accuracy of more than ninety percent and is used for the prediction of the disease using the vocal features extracted from the person. This algorithm is trained with the dataset which contains both normal as well as the affected person’s voice features. Decision tree classifier algorithm, Logistic Regression, and that of the Support Vector Machine Algorithm are used as the input for the voting classifier which is used for detecting the disease.


Author(s):  
Nuriye Yıldırım Gökay ◽  
Bülent Gündüz ◽  
Fatih Söke ◽  
Recep Karamert

Purpose The effects of neurological diseases on the auditory system have been a notable issue for investigators because the auditory pathway is closely associated with neural systems. The purposes of this study are to evaluate the efferent auditory system function and hearing quality in Parkinson's disease (PD) and to compare the findings with age-matched individuals without PD to present a perspective on aging. Method The study included 35 individuals with PD (mean age of 48.50 ± 8.00 years) and 35 normal-hearing peers (mean age of 49 ± 10 years). The following tests were administered for all participants: the first section of the Speech, Spatial and Qualities of Hearing Scale; pure-tone audiometry, speech audiometry, tympanometry, and acoustic reflexes; and distortion product otoacoustic emissions (DPOAEs) and contralateral suppression of DPOAEs. SPSS Version 25 was used for statistical analyses, and values of p < .05 were considered statistically significant. Results There were no statistically significant differences in the pure-tone audiometry thresholds and DPOAE responses between the individuals with PD and their normal-hearing peers ( p = .732). However, statistically significant differences were found between the groups in suppression levels of DPOAEs and hearing quality ( p < .05). In addition, a statistically significant and positive correlation was found between the amount of suppression at some frequencies and the Speech, Spatial and Qualities of Hearing Scale scores. Conclusions This study indicates that medial olivocochlear efferent system function and the hearing quality of individuals with PD were affected adversely due to the results of PD pathophysiology on the hearing system. For optimal intervention and follow-up, tasks related to hearing quality in daily life can also be added to therapies for PD.


2004 ◽  
Vol 9 (2) ◽  
pp. 10-13
Author(s):  
Linda Worrall ◽  
Jennifer Egan ◽  
Dorothea Oxenham ◽  
Felicity Stewart

2007 ◽  
Vol 12 (1) ◽  
pp. 2-11
Author(s):  
Lorraine Ramig ◽  
Cynthia Fox

Sign in / Sign up

Export Citation Format

Share Document